CTRI/2019/07/020144已完成4 期
Clinical assessment of glycopyrronium and arformoterol home nebulization in high-risk, symptomatic COPD: SYMPTOM study.
Glenmark Pharmaceuticals Ltd0 个研究点目标入组 49 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 49
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Hospitalized or Post-discharge cases of COPD
- •2. COPD cases with history of >=1 exacerbation in last year
- •3. Patients willing for follow-up visit.
排除标准
- •1. Patients with < 1 follow up visit to be excluded from the analyses
- •2. Personal history of Bronchial asthma
- •3. Patients with history on use of oxygen therapy >12 hours/day
- •4. Patients with any history of unstable disease and/or recent hospitalization due to COPD prior to six weeks of study observation
研究者
相似试验
未知
2 期
Efficacy and safety of four doses of glycopyrronium bromide in patients with stable COPD, in comparison to an active comparator tiotropium.Chronic Obstructive Pulmonary Disease (COPD)JPRN-jRCT2080220418ovartis Pharma K.K.73
已完成
4 期
Assessment of Glycopyrrolate in patients with breathing problems.CTRI/2018/04/012944Glenmark Pharmaceuticals Ltd1,215
尚未招募
4 期
Double treatment with Glycopyrronium and Indacaterol versus single treatment with Glycopyrronium in treatment of lung diseasepulmonary emphysemapulmonary diseasechronic obstructiveC08.381.495.389.750C08.381.495.389RBR-7k576jHospital de Clínicas da Universidade Federal do Paraná
尚未招募
3 期
Evaluation of the effects of Gluronic acid in HTLV-1 patientspatients with HTLV-1 associated myelopathy.Human T-cell lymphotrophic virus, type I [HTLV-I] as the cause of diseases classified elsewhereB97.33IRCT20180618040127N1Mashhad University of Medical Sciences40
招募中
不适用
Prevention of spinal hypotension during caesarean sectioCTRI/2020/11/028792Vinayaka Missions Medical college